These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38869489)

  • 1. Phase 1 study of the iodine absorption, safety, and tolerability of a 0.5% povidone-iodine nasal spray (Nasodine).
    Friedland PL; Polasek TM; Topliss D
    Int Forum Allergy Rhinol; 2024 Jun; ():. PubMed ID: 38869489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II Trial of the Impact 0.5% Povidone-Iodine Nasal Spray (Nasodine®) on Shedding of SARS-CoV-2.
    Friedland PL; Tucker S
    Laryngoscope; 2024 Mar; ():. PubMed ID: 38554057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro safety evaluation of a povidone-iodine solution applied to human nasal epithelial cells.
    Ramezanpour M; Smith JLP; Psaltis AJ; Wormald PJ; Vreugde S
    Int Forum Allergy Rhinol; 2020 Oct; 10(10):1141-1148. PubMed ID: 32250552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: A structured summary of a study protocol for an open-label randomized clinical trial.
    Hasan MJ; Rumi SKNF; Banu SS; Uddin AKMN; Islam MS; Arefin MK
    Trials; 2021 Jan; 22(1):2. PubMed ID: 33397432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro Nasodine Can be an Effective Antibiofilm Agent for Biofilms that May Cause CRS.
    Hale SJM; Lux CA; Kim R; Biswas K; Tucker S; Friedland P; Mackenzie BW; Douglas RG
    Laryngoscope; 2023 Oct; 133(10):2490-2495. PubMed ID: 36644968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2.
    Frank S; Brown SM; Capriotti JA; Westover JB; Pelletier JS; Tessema B
    JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1054-1058. PubMed ID: 32940656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical study on the tolerability of a liposomal povidone-iodine nasal spray: implications for further development.
    Gluck U; Martin U; Bosse B; Reimer K; Mueller S
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(2):92-9. PubMed ID: 17148942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Povidone-Iodine Nasal Spray on Nasopharyngeal SARS-CoV-2 Viral Load: A Randomized Control Trial.
    Zarabanda D; Vukkadala N; Phillips KM; Qian ZJ; Mfuh KO; Hatter MJ; Lee IT; Rao VK; Hwang PH; Domb G; Patel ZM; Pinsky BA; Nayak JV
    Laryngoscope; 2022 Nov; 132(11):2089-2095. PubMed ID: 34724213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pilot Study of 0.4% Povidone-Iodine Nasal Spray to Eradicate SARS-CoV-2 in the Nasopharynx.
    Sirijatuphat R; Leelarasamee A; Puangpet T; Thitithanyanont A
    Infect Drug Resist; 2022; 15():7529-7536. PubMed ID: 36575672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
    Pelletier JS; Tessema B; Frank S; Westover JB; Brown SM; Capriotti JA
    Ear Nose Throat J; 2021 Apr; 100(2_suppl):192S-196S. PubMed ID: 32951446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: an open-label randomized clinical trial.
    Arefin MK; Rumi SKNF; Uddin AKMN; Banu SS; Khan M; Kaiser A; Chowdhury JA; Khan MAS; Hasan MJ
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2963-2967. PubMed ID: 34026595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability and effectiveness of povidone-iodine or mupirocin versus saline sinus irrigations for chronic rhinosinusitis.
    Lee VS; Pottinger PS; Davis GE
    Am J Otolaryngol; 2020; 41(5):102604. PubMed ID: 32563787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era.
    Frank S; Capriotti J; Brown SM; Tessema B
    Ear Nose Throat J; 2020 Nov; 99(9):586-593. PubMed ID: 32520599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Povidone Iodine (PVP-I) Oro-Nasal Spray: An Effective Shield for COVID-19 Protection for Health Care Worker (HCW), for all.
    Arefin MK
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2906-2911. PubMed ID: 33846691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quality improvement study on the relationship between intranasal povidone-iodine and anesthesia and the nasal microbiota of surgery patients.
    Hammond EN; Kates AE; Putman-Buehler N; Watson L; Godfrey JJ; Brys N; Deblois C; Steinberger AJ; Cox MS; Skarlupka JH; Haleem A; Bentz ML; Suen G; Safdar N
    PLoS One; 2022; 17(12):e0278699. PubMed ID: 36490265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic.
    Khan MM; Parab SR; Paranjape M
    Am J Otolaryngol; 2020; 41(5):102618. PubMed ID: 32574894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual complication of late onset allergic contact dermatitis to povidone iodine in oral & maxillofacial surgery - a report of 2 cases.
    Reyazulla MA; Gopinath AL; Vaibhav N; Raut RP
    Eur Ann Allergy Clin Immunol; 2014 Jul; 46(4):157-9. PubMed ID: 25053635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the antimicrobial efficacy of povidone-iodine, povidone-iodine-ethanol and chlorhexidine gluconate-ethanol surgical scrubs.
    Nishimura C
    Dermatology; 2006; 212 Suppl 1():21-5. PubMed ID: 16490971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of diluted topical povidone-iodine rinses in the management of recalcitrant chronic rhinosinusitis: a prospective cohort study.
    Panchmatia R; Payandeh J; Al-Salman R; Kakande E; Habib AR; Mullings W; Javer AR
    Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3373-3381. PubMed ID: 31560120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of povidone-iodine nasal rinse and mouth wash in COVID-19 management: a prospective, randomized pilot clinical trial (povidone-iodine in COVID-19 management).
    Alsaleh S; Alhussien A; Alyamani A; Alhussain F; Alhijji A; Binkhamis K; Khan A; Javer A; Alshahrani FS
    BMC Infect Dis; 2024 Mar; 24(1):271. PubMed ID: 38429662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.